Clark+Elbing
Vincent Primo is a Patent Agent at Clark+Elbing LLP, specializing in the drafting and prosecution of patent applications since February 2021. Previously, Vincent served as a Technology Specialist and Postdoctoral Fellow at Boston College, where work focused on optimizing ATAC-sequencing protocols and investigating genetic virulence factors in Toxoplasma gondii during a PhD candidacy. Early research experience includes roles as a Research Technician at Schepens Eye Research Institute, where a biomarker for CADASIL was discovered, and as a Research Intern at Harvard Catalyst, which involved asthma biomarker investigations. Educational credentials comprise a Doctor of Law (JD) degree from New England Law | Boston, a PhD in Molecular Biology from Boston College, and a Bachelor of Science in Biology from the University of Massachusetts Amherst.
Clark+Elbing
Clark+Elbing is a top-tier intellectual property (IP) law firm focused on protecting and promoting innovations in life science, chemistry, devices, and diagnostics. Founded in 1996 by a group with a shared passion for science, our firm has a long-held reputation as a premier law firm for patents. We are proud to offer a robust team of IP attorneys with advanced degrees in science who are supported by a group of Ph.D.s who are at the forefront of scientific innovation. We are as curious, collaborative, precise, and creative as you are. We are unapologetic science enthusiasts with a deep appreciation for technology. We understand what it is, how it works, why it matters – and what it is worth. That’s why clients like you prefer to work with us. We get it, and we get you. Our clients span the business spectrum and the globe. We represent clients from start-ups to multinational corporations and the investors that fund them, as well as world-class universities and medical centers.